Afyren, a greentech company that offers manufacturers natural, low-carbon products created with technology based on natural micro-organisms, has signed two contracts for the long-term supply of biobased ingredients by Afyren Neoxy to two players in the nutrition (human and animal) and health markets.
The two contracts were established with companies considered to be leaders in their sectors:
- The first is for the manufacture of high-quality food ingredients, particularly for the confectionery, meat, chocolate and dairy markets.
- The second is for the manufacture of nutritional and health products for animals.
The markets addressed by these partners have significant growth potential amid increasing consumer demand for natural and bio-based products. Afyren is responding to these trends by ensuring a local supply chain for the raw materials used by its Afyren Neoxy plant and through its proprietary technology platform.
Data Bridge Market Research* analysis shows that the animal nutrition market is expected to grow at a compound annual growth rate of 6.5% for the 2021 to 2028 period. The human nutrition market is growing at a similar rate, according to a report from Wellness Creative Co.**
According to the company, taking into account these deals, 60% (by volume) of the organic acid output to be produced by the Afyren Neoxy plant is already pre-sold.
Afyren CEO, Nicolas Sordet, said, "In the wake of the recently announced partnership with Ennoluys, these two new agreements underscore the attractiveness of our products and our unique positioning—based on a circular economy and a zero-industrial-waste approach. The markets we will be addressing are growing steadily and are experiencing significant demand for sustainable and biobased ingredients, driven by consumers who are seeking healthier and more responsible lifestyles. By ensuring the supply of these two leading players in animal nutrition and human food, we are taking additional steps to secure future revenue for Afryen Neoxy while positioning ourselves as a leading supplier of bio-based organic acids at the European level. This allows us to continue to guarantee a successful start for this first plant and approach its ramp-up with confidence."